ArticleJournal of pharmaceutical policy and practice2025
Pharmacist prescriber in Italy and possible changes to current legislation:
Article in Journal of pharmaceutical policy and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Stakeholders' views of the implementation of pharmacist prescribing in the community pharmacy setting: a mixed-methods systematic review.Exploratory research in clinical and social pharmacy · 2026Review
- Pharmacist-Led Prescribing in Austria: A Mixed-Methods Study on Clinical Readiness and Legal Frameworks.Pharmacy (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In many countries in Europe and in the world, pharmacists are allowed to prescribe or modify therapies. In Italy, the only healthcare professions authorised to prescribe are medical doctors and veterinary surgeons. The extension of the duties of the Italian pharmacist to include prescribing would be extremely important considering the challenges the National health system is facing regarding the shortage of healthcare workers. Methods: In this article, we report the findings of a survey on the role of the pharmacist prescriber conducted among pharmacists, family doctors, and pharmacy users in the North-West of Italy. The investigation was conducted by means of interviews carried out, using category-specific questionnaires. Results: Interviews were conducted with 234 pharmacists, 926 users and 9 family doctors. The majority of pharmacists and users would agree to the introduction of the prescribing pharmacist. In return for taking on the increased responsibility, the pharmacists stressed the need for appropriate legal status and additional training. The reasons most commonly indicated by pharmacists for introducing such a service are the ability to respond immediately to a pathology or minor condition, and the prevention of inappropriate self-medication by patients. More than three-quarters of pharmacists and family doctors feel that the most suitable pharmacist prescribing procedure would be that within a clinical management plan. The family doctors, expressed reservations regarding the pharmacist prescriber: the cases in which they were really open to a change were the renewal of a prescription. Conclusions: This study highlights the fact that both pharmacists and pharmacy users tend to be favourable to the introduction of the figure of the pharmacist prescriber in Italy. Many obstacles remain to be overcome but, based on the procedures already experimented in other European countries and worldwide, a route leading to the introduction of the pharmacy prescriber role may be hypothesised.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.